TREA

88171179 - CIPLA

Follow

Information

  • Trademark
  • 88171179
  • Serial Number
    88171179
  • Registration Number
    5894625
  • Filing Date
    October 26, 2018
    5 years ago
  • Registration Date
    October 29, 2019
    4 years ago
  • Transaction Date
    October 29, 2019
    4 years ago
  • Status Date
    October 29, 2019
    4 years ago
  • Published for Opposition Date
    August 13, 2019
    4 years ago
  • Location Date
    October 29, 2019
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    NITKIN, DINISHA F
  • Attorney Docket Number
    CIPLA164TM
    Attorney Name
    Usha Menon
    Law Office Assigned Location Code
    M10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
CIPLA
Case File Statements
  • GS0051: Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of gastro-intestinal disorders, disorders of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, seizures Huntington's disease, multiple sclerosis; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of disorders of the respiratory system, heart conditions and other disorders of the cardiovascular system, namely, Coronary artery disease, Heart attack, abnormal heart rhythms, arrhythmias, heart failure, heart valve disease, congenital heart disease, cardiomyopathy, pericardial disease; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of migraines and other forms of headache, namely, sinus headaches, tension headaches, cluster headaches and rebound headaches; pharmaceutical and medicinal preparations, namely, analgesics; pharmaceutical and medicinal preparations, namely, antiviral and anti-retroviral pharmaceutical preparations for the treatment of viral brain diseases; pharmaceutical and medicinal preparations, namely, anti-infectives; pharmaceutical and medicinal preparations, namely, anti-inflammatories; pharmaceutical and medicinal preparations, namely, antibiotics; pharmaceutical and medicinal preparations, namely, antidepressants; pharmaceutical and medicinal preparations, namely, anti-cancer preparations; pharmaceutical and medicinal preparations, namely, medicated soaps and lotions for the skin and hair, namely, medicated acne lotion, medicated body moisturizing lotion, medicated lotion for eczema and seborrheic dermatitis, medicated hair shampoo and hair scalp lotion, medicated anti-dandruff lotion; pharmaceutical and medicinal preparations, namely, decongestants and antihistamines; pharmaceutical and medicinal preparations, namely, scabicides; pharmaceutical and medicinal preparations, namely, anti-malarials; pharmaceutical and medicinal preparations, namely, cough suppressants; pharmaceutical and medicinal preparations, namely, cough and cold preparations; pharmaceutical and medicinal preparations, namely, expectorants; pharmaceutical and medicinal preparations, namely, anti-leukemic agents; pharmaceutical and medicinal preparations, namely, tissue sealants; pharmaceutical and medicinal preparations, namely, vasopressors; pharmaceutical and medicinal preparations, namely, nondepolarizing skeletal neuromuscular blocking agents; pharmaceutical and medicinal preparations, namely, preparations for the treatment of gout; pharmaceutical and medicinal preparations, namely, preparations for cessation of smoking; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of genitourinary diseases and disorders, namely, urological diseases, urological disorders, urinary incontinence, infertility, sexually transmitted diseases, inflammatory pelvic diseases; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of pain from burns, hemolytic diseases and disorders, neuropathic pain; Pharmaceutical and medicinal preparations for the treatment, alleviation and prevention of fibromyalgia, post-herpetic neuralgia, chronic pain, obesity, inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), viral diseases and disorders, namely, herpes, hepatitis, substance abuse disorders, namely, alcoholism and drug addiction, carpel tunnel syndrome, varicose veins, dental and oral diseases, osteoporosis, arthritis, yeast infections, prostate disorders, pulmonary disorders, sleep disorders, namely, insomnia and, restless leg syndrome, premature ejaculation, macular degeneration, thrombosis and thromboembolism; pharmaceutical and medicinal preparations, namely, vaccines for human use; pharmaceutical and medicinal preparations, namely, adjuvants for use with human vaccines; pharmaceutical and medicinal preparations in the nature of veterinary preparations, namely, flea and tick preparations, vaccines, anti inflammatories, mastitis preparations, and oncological preparations
Case File Event Statements
  • 10/29/2019 - 4 years ago
    19 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/13/2019 - 4 years ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/13/2019 - 4 years ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/24/2019 - 4 years ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/8/2019 - 4 years ago
    15 - ASSIGNED TO LIE Type: ALIE
  • 6/27/2019 - 5 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/27/2019 - 5 years ago
    13 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/27/2019 - 5 years ago
    12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/27/2019 - 5 years ago
    11 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/27/2019 - 5 years ago
    10 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/7/2019 - 5 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/6/2019 - 5 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/6/2019 - 5 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/4/2019 - 5 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/4/2019 - 5 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/4/2019 - 5 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/4/2019 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/9/2018 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 10/30/2018 - 5 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP